Japan, Oct. 30 -- BOEHRINGER INGELHEIM INTERNATL GMBH,VIRATHERAPEUTICS GMBH has got intellectual property rights for 'RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21.' Other related details are as follows:
Application Number: JP,2023-129810
Category (FI): C12N15/12,A61K31/5377,A61K35/766,A61K39/395@T,A61K39/395@U,A61K45/00,A61P35/00,A61P43/00,121,A61K31/506,C12N15/33,A61K31/4725,C12N5/10,C12N7/01,A61K31/4709,A61K31/444
Stage: Grant (IP right document published.)
Filing Date: Aug. 9, 2023
Publication Date: Oct. 2, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
